Category Archives: Supply Chain

04Oct/21

Digital Transformation: The Business Imperative for Life-Sciences

By Daniel R. Matlis, President

“Necessity is the mother of invention,” says the ancient proverb.  In my opinion, the corollary is: “disruption is the matriarch of transformation,” especially for the Life-Sciences industries.

The COVID-19 epidemic has been the biggest global disruption in our generation. It represents a watershed moment for transformation throughout our industry.

Disruption is the new normal. This new paradigm is forcing Life-Science companies to re-imagine the way they operate; transforming and accelerating product development, regulatory review, manufacturing, and distribution cycles aimed at improving patient outcomes.

Continue reading
14Apr/21

Q: Who is the Best Technology Vendor? A: NONE!

An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings

By: Daniel R. Matlis

As a Life-Science Industry Analyst, I am often asked by executives to recommend the best technology vendor.

My standard answer:  None, there is no such thing as a “best vendor.”   

Just like an automotive industry analyst could not recommend the “best car” for you until they know your budget, unique requirements, and primary use; a Life Science industry analyst must understand your company’s intended use, business, regulatory and technology requirements, as well as organizational culture before recommending a system.

Yet for decades, Life-Science industry executives have relied on forced rankings from analyst firms to identify the top five vendors to invite for an RFP.  This is especially true when evaluating the alphabet soup of system acronyms (AI/ML, APS, CTMS, CM&S, EAM, EDC, ERP, LIMS, MES, PLM, RIM, SCM, etc., etc., etc.)

Continue reading
31Mar/21

Pfizer Uses Positive Disruption to Manage Product Design Across the Lifecycle

COVID-19 forced Life-Science companies to reimagine the way they operate. Pfizer has adapted its Culture, Systems and Processes to drive increased visibility, control and collaboration that have achieved unprecedented results.


Join Pfizer’s Hugo Felix and Axendia’s Daniel R. Matlis for a “Straight from the Source” live webinar on 21-APR-2021 at 11:30 AM ET as they discuss how Pfizer is using Positive Disruption to manage product design across the lifecycle.

15Mar/21

Digital Transformation Builds Trust Across the Value Network

Disruptions have eroded trust across Life-Science supply chains forcing brand owners to re-evaluate outsourcing programs in favor of Smart-Sourcing strategies that focus on quality, resilience, and value, instead of cost.

As a result, innovative CMOs, like Ori Biotech and SteriPack, are modernizing and digitally transforming their manufacturing operations to support Quality Metrics, Review by Exception and Smart-Sourcing.  

Continue reading
22Feb/21

SAP Re-Imagines Supply Chain Collaboration

SAP Briefing Note

By Daniel R. Matlis

SAP’s Life Sciences leadership team recently briefed Axendia on its re-imagined Supply Chain Collaboration strategy.

Globalization and outsourcing have increased the volume of geographically dispersed partners, facilities, and suppliers in the Life-Science global supply chain. This has resulted in increased supply chain risk and decreased predictability due to variability and complexity and increasing the impact of ‘Black Swan’ events on the healthcare ecosystem. 

Axendia’s research shows that Life-Sciences companies are making the transition to ‘Smart Sourcing’ to achieve visibility control and collaboration beyond the corporate four  walls across into their Value Network.  

Re-imagining Supply Chain Collaboration

To support re-imagined supply chain collaboration, SAP is expanding its offerings to the Life Science industry building on the strength of its Ariba supplier network to support multiple sourcing strategies, as well as the underlying procurement business processes.  

Continue reading